AW

Abhijit Waghmare

Active Director Director DIN 11533611
DIN 11533611 First appointment Feb 2026 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Feb 2026
Shareholding value β€’β€’β€’β€’ Premium profile

About Abhijit Waghmare

Data last updated:

Abhijit Waghmare is a Director at Shubalk Pharmaceuticals Private Limited (since 2026). The company operates in Pharma.

DIN 11533611
Primary Designation Director
Industry Pharma
First Appointment 09 Feb 2026

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director09 Feb 20262026Active

Board colleagues of Abhijit Waghmare

NameDINCompanyDesignation
Alka Subhash Waghmare11533612Shubalk Pharmaceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Shubalk Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Abhijit Waghmare

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Abhijit Waghmare

Abhijit Waghmare currently holds 1 directorship: Shubalk Pharmaceuticals Private Limited (Director, since 09 Feb 2026).

Abhijit Waghmare was first appointed on 09 Feb 2026 as Director at Shubalk Pharmaceuticals Private Limited.

The current boards of Abhijit Waghmare's companies include Alka Subhash Waghmare (Shubalk Pharmaceuticals Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available